Search Results

ABOUT THE GUEST Michel Bouvier is CEO of the Institut de Recherches Cliniques de Montreal (IRCM) and Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Institute for Research in Immunology and Cancer ( IRIC ) at the Université de Montréal. Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. He has supervised the research work of 75 graduate students and 40 post-doctoral fellows.

Learn about Celtarys Research through the Dr. GPCR Ecosystem. Visit Website About Celtarys Research Celtarys Research develops and commercializes new chemical tools are involved in several pathologies, ranging from neurological, oncological, degenerative, metabolic, immunological , CEO of Celtarys Research. /celtarys-research Services & Expertise NEW!

In pancreatic cancer, proton-sensing GPCRs such as GPR68 are dramatically upregulated in cancer-associated in animal models, particularly in pancreatic cancer. cancer-associated fibroblasts — not the cancer cells themselves. , immunology, and systems biology. Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles

About the Guest Ross Cheloha is a tenure-track investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health. His research combines peptide chemistry, chemical biology, and nanobody engineering to build mechanistic pharmacology: calcium spikes, bone biology, and why long-acting isn't always better 23:22 A detour into immunology Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic

Annette Gilchrist has built her research program around that premise. Her lab studies chemokine receptor CCR1 in multiple myeloma and cancer-to-bone metastasis, free fatty episode. 00:00 Introduction 02:18 Career trajectory - from medical school intent to Pfizer, PhD in immunology , and muscarinic M2 and M3 19:28 CCR1 in multiple myeloma - osteoclast/osteoblast imbalance and the cancer-to-bone Gilchrist completed her Ph.D. in Biomedical Sciences / Immunology at the University of Connecticut and

This week's GPCR roll-up includes the latest insights, research discoveries, and advancements. We'll also preview upcoming courses designed for both experienced researchers and newcomers. 🚀 Develop Conformational Landscapes Rajan Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Cortical astrocyte activation triggers meningeal nociception and migraine-like pain GPCRs in Oncology and Immunology mediators of tumour-to-TME crosstalk Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer

Scholar period I have published or contributed in 38 published scientific work mainly in the field of immunology The majority of my research is concentrated on rhodopsin family with a few works on metabotropic receptor Pierre Eftekhari on the web Inoviem Scientific ResearchGate LinkedIn Twitter Dr.

The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers Cardarelli heads the team of talented researchers that will be expanding at the US site. Dr. She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology

neuropsychiatric disease: addiction, autism spectrum disorder, schizophrenia, bipolar disorder, and cancer through the lens of adhesion GPCR biology — addiction, autism spectrum disorder, schizophrenia, and cancer field in an underrepresented scientific ecosystem, and recruiting from communities elite institutions why structures are finally coming 01:09:10 Synapse formation, addiction, autism, schizophrenia, and cancer In this institution dear to the heart of GPCR enthusiasts given that its faculty personnel included Dr

Nikolaus Heveker's lab at the CHU Sainte-Justine Research Center on chemokine receptor structure–function Her career has moved through academic pharmacology, a research fellowship in B-cell molecular immunology The lab had no equipment, only stacks of bills on every bench — and a research program on chemokines are the connective tissue a 400-receptor field uses to exchange techniques, ideas, and trust across institutional During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.

stabilization, allosteric modulation, and the pharmacology of receptor families implicated in neuroscience, immunology translation failure Orphan GPCRs and the missing pharmacology of ~100 unassigned receptors GPCRs in oncology, immunology Oncology Ignored GPCRs for Decades — and Is Paying Attention Now Twenty years ago, cancer biologists the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research

University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer , and cancer and is an important drug target. From 1987 to 1994, they were the Director of Biocomputing at The Salk Institute, where they managed institute-wide

During my Ph.D. at the International Max Planck Research School “The Leipzig School of Human Origins” Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig Our ultimate goal is to understand their role in immune cell function and cancer cell metabolism. " Dr Claudia Stäubert on the web Stäubert Lab, Rudolf Schönheimer Institute of Biochemistry Leipzig LinkedIn GPCR, discussed with Claudia, a guest from the Schiller Institute at Campstream, about Claudia's work

Catherine Demery shares how she found clarity and purpose in academic opioid research. building translational experiments, and using real-world data to drive impactful science in the GPCR research Her research combines cutting-edge GPCR signaling studies with real-time public health data from Michigan The role of public health programs in informing lab research. Her next stop: the NIH, studying the immunology of pregnancy.

began as a focused exploration into Family B GPCRs evolved into a comprehensive resource for the GPCR research These tools are fully open to academic researchers , with wide applicability beyond just RAMPs — including autoantibodies activate GPCRs , potentially driving pathophysiology — a paradigm-shifting concept in GPCR immunology Sakmar reflects on the generational shift in research culture. Ilana’s research is multi-disciplinary and involves a close collaboration with the lab of proteomics

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Caron on the web UNC-Chapel Hill Department of Cell Biology and Physiology UNC Lineberger Comprehensive Cancer In addition to research, Dr. Program and is working to build relationships with key stakeholders through institutional and community

Ines Liebscher About Dr. Being a biochemist by training, she completed her Ph.D. at the Institute of Biochemistry at the University Ines Liebscher Dr. Liebscher is a Professor at the Rudolf Schönheimer Institute of Biochemistry at the Medical Faculty of Ines Liebscher on the web Website LinkedIn Researchgate Dr. GPCR Ecosystem Unlock the Full Dr.

Françoise Bachelerie " FB leads a team at Paris-Saclay University with expertise in immunology and virology CXCR7) receptors of the CXCL12 chemokine, key effectors of the immune system, including their role in immunological Françoise Bachelerie on the web INSERM ResearchGate SciSpace Loop LinkedIn Dr.

<< Back to podcast list Strategic Partner(s) Exploring Career Paths in GPCR Research with Dr. After completing his Ph.D., he pursued research in genetics of metabolic regulation at the Institute of Metabolic Science - Metabolic Research Laboratories at the University of Cambridge in the team led of method development, integrity, and honesty in scientific research. their research interests and achievements, particularly in the field of GPCR.

A fresh look at computational GPCR research. << Back to podcast list Strategic Partner(s) Smells Like discovery… I was in love with the topic.” – Alessandro Nicoli Working on docking and NMR studies for cancer-related From Researcher to Mentor: Growing Together Outside his research, Nicoli mentors students, manages interns Antonella Di Pizio at the Leibniz Institute for Food Systems Biology at the Technical University of Munich Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

professor and chair of the Department of Computational and Quantitative Medicine (DCQM) at the Beckman Research Institute of the City of Hope in Los Angeles, CA. She is also the Associate Director of the City of Hope Comprehensive Cancer Center. Dr. Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where Vaidehi joined the Beckman Research Institute of the City of Hope in 2006 as a Professor and became chair

Gloriam's research addresses a central challenge in the field: how to move from a bare protein sequence For Gloriam, this work began with a grandmother's cancer diagnosis and an early determination to develop His primary research focus is orphan GPCR biology, with particular emphasis on identifying endogenous could surface big unsolved problems, correspond across institutions, design experiments collectively He completed two postdocs in the UK at the EMBL-European Bioinformatics Institute and GlaxoSmithKline

every tissue and implicated in conditions ranging from Parkinson's disease to ischemic heart disease to cancer Eleonora Comeo, PhD candidate at the University of Nottingham and the Monash Institute of Pharmaceutical For Comeo, who entered GPCR research without any background in the field and built her PhD around chemistry GUEST Eleonora Comeo is a PhD candidate jointly enrolled at the University of Nottingham and the Monash Institute HEK cells are a known confound that still catch researchers out HEK cells endogenously express A2A and

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute of Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department at the Institute of Pharmacology Russian Academy of Medical Sciences in Moscow (1988-1996). Gainetdinov was included in the Web of Science (WOS) Highly Cited Researchers (HCR) list, representing

Johannes Broichhagen Group Leader Leibniz Research Institute for Molecular Pharmacology (FMP), Berlin doctorate at LMU Munich in 2014, and undertook postdoctoral work at EPFL (Switzerland) and the Max Planck Institute for Medical Research (Heidelberg). He previously served as Professor of Cellular Metabolism and Institute Deputy Director at the University Cancel anytime. Sign Up for Free

Silvio Gutkind on keeping a cancer research lab running at 10% occupancy, why rotation students act like His research spans GPCR signaling in cancer biology, head and neck squamous cell carcinoma, and the molecular Scientific Themes of the Conversation Institutional resilience and the architecture of a research lab Gutkind describes operating his cancer research building at 93–94% capacity during the early pandemic during the pandemic 03:30 Why cancer research couldn't stop 04:30 The NIH shutdown playbook 05:20 Writing